Page last updated: 2024-08-25

diflorasone and clobetasol

diflorasone has been researched along with clobetasol in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's4 (50.00)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jegasothy, BV1
Katz, HI; Prawer, SE1
Renovanz, HD; Rozman, TA; Wiedey, KD1
Aso, M1
Francom, SF; Novak, E; Schlagel, CA1
Amin, S; Kashani-Sabet, M; Zackheim, HS1
Garzon, MC; Paller, AS1
Hecker, D; Lebwohl, M; Worsley, J; Yueh, G1

Trials

4 trial(s) available for diflorasone and clobetasol

ArticleYear
Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
    International journal of dermatology, 1990, Volume: 29, Issue:10

    Topics: Betamethasone; Clobetasol; Double-Blind Method; Humans; Ointments; Psoriasis

1990
[Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
    Zeitschrift fur Hautkrankheiten, 1983, Mar-15, Volume: 58, Issue:6

    Topics: Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Humans; Photochemotherapy; Psoriasis; PUVA Therapy

1983
Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
    Clinical therapeutics, 1983, Volume: 6, Issue:1

    Topics: Adult; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Ointments; Pituitary-Adrenal System; Random Allocation

1983
Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus.
    Archives of dermatology, 1999, Volume: 135, Issue:5

    Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Child; Child, Preschool; Clobetasol; Female; Follow-Up Studies; Genital Diseases, Female; Glucocorticoids; Humans; Lichen Sclerosus et Atrophicus

1999

Other Studies

4 other study(ies) available for diflorasone and clobetasol

ArticleYear
Guidelines for using superpotent topical steroids.
    American family physician, 1990, Volume: 41, Issue:5

    Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Skin Diseases

1990
The effects of potent topical corticosteroids on adrenocortical function.
    The Journal of dermatology, 1983, Volume: 10, Issue:2

    Topics: Administration, Oral; Administration, Topical; Adrenal Cortex; Adult; Anti-Inflammatory Agents; Betamethasone; Budesonide; Clobetasol; Diflucortolone; Dose-Response Relationship, Drug; Eczema; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Pregnenediones; Psoriasis

1983
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
    Archives of dermatology, 1998, Volume: 134, Issue:8

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Betamethasone; Betamethasone Valerate; Clobetasol; Drug Administration Schedule; Female; Fluocinonide; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Occlusive Dressings; Prospective Studies; Remission Induction; Skin Neoplasms; Treatment Outcome; Triamcinolone Acetonide

1998
In vitro compatibility of tazarotene with other topical treatments of psoriasis.
    Journal of the American Academy of Dermatology, 2000, Volume: 42, Issue:6

    Topics: Administration, Topical; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Evaluation, Preclinical; Drug Incompatibility; Fluocinonide; In Vitro Techniques; Mometasone Furoate; Nicotinic Acids; Pregnadienediols; Psoriasis

2000